MTOR and nonpapillary renal cell carcinoma: Collectively, we have generated a schematic diagram illustrating the progression of FAP promoted ccRCC through the activation of the PI3K/AKT/mTOR signaling pathway, highlighting FAP as a promising therapeutic target for ccRCC (Fig. 9).